Solitron Devices 10% holder plans sale of up to 20,000 shares
Control and investment authority over the fund's shares are attributed to its general partner, investment manager and Christian Olesen.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Solitron Devices Inc. received notice that Olesen Value Fund L.P., identified as a 10% stockholder, intends to sell up to 20,000 common shares through broker(s) listed, including Auerbach Grayson & Company LLC. The shares are owned by the fund and controlled by Olesen Value Fund GP LLC as general partner, Olesen Capital Management LLC as investment manager, and Christian Olesen, managing member of both LLCs. Securities information lists an aggregate market value of $665,800.00 and 2,152,703 shares outstanding.
Key Figures
Key Terms
Rule 144 regulatory
good funds financial
regular trade settlement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.